Welcome to the e-CCO Library!

P717: The use of combination biologic therapy in inflammatory bowel disease: A single tertiary-centre experience
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

N. Panaccione*1, K. Novak1, C. Seow1, S. Devlin1, C. Lu1, J. Heatherington1, M-L. Martin1, G. Kaplan1, R. Panaccione1

Created: Friday, 22 February 2019, 9:41 AM
P717: Use of tramadol versus traditional opioids and adverse outcomes of Inflammatory Bowel Diseases: a Danish nationwide cohort study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Dalal, R.(1)*;Lund, K.(2);Zegers, F.(2);Friedman, S.(1);Allegretti, J.(1);Norgard, B.(2);
Created: Friday, 14 July 2023, 11:12 AM
P718 Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Matar1, R. Shamir1, D. Turner2, E. Broide3, B. Weiss4, O. Ledder2, A. Guz-Mark1, F. Rinawi1, S. Cohen5, C. Topf Olivestone6, R. Shaul7, S. Ben-Horin8, A. Assa1

Created: Thursday, 30 January 2020, 10:12 AM
P718: A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Otero Piñeiro, A.(1)*; Lightner , A.L.(1);Reese , J.(2);Ream , J.(3);Nachand , D.(4);Adams , A.(5);VanDenBossche, A.(1);Kurowski, J.(6);
Created: Friday, 14 July 2023, 11:12 AM
P718: Characterization of microbiota and metabolomic profile in human colonic surgical resections of UC patients
Year: 2022
Source: ECCO'22
Authors: Bauset, C.(1);Carda-Diéguez, M.(2);Buetas, E.(2);Lis-López, L.(1);Navarro, F.(3);Ortiz-Masiá, D.(4);Calatayud, S.(1);Barrachina, M.D.(1);Mira, Á.(2);Cosín-Roger, J.(5);
Created: Friday, 11 February 2022, 3:56 PM
P718: Discrepancies between patients’ preferences and physicians’ preference perception for oral formulations: A real-life survey
Year: 2018
Source: ECCO '18 Vienna
Authors:

P. Marchi1*, S. Timeus1, L. Mackenzie-Smith1, P. Le Calvé2, R. Young2

Created: Thursday, 21 February 2019, 9:14 AM
P718: Risk of tuberculosis in patients with inflammatory bowel disease receiving biologics using two interferon-γ release assays as monitoring
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. de Francisco*1,2, M. Arias-Guillén3, A. Castaño-García1, I. Pérez-Martínez1, J. J. Palacios4, V. Rolle-Sóñora2, S. Martínez-González1, V. Jiménez-Beltrán1, N. Rodríguez-Ferreiro1, P. Flórez-Díez1, A. Suárez1,2, S. Riestra1,2

Created: Friday, 22 February 2019, 9:41 AM
P718: The epidemiology of IBD differs in South Asian migrants compared to Caucasians; results from a systematic review and meta-analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Misra R.*1, Faiz O.2, Burisch J.3, Munkholm P.3, Arebi N.4

Created: Wednesday, 20 February 2019, 10:36 AM
P719 Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Amiot1, A. Vered2, J. Filippi3, G. Cadiot4, D. Laharie5, S. Melanie6, R. Altwegg7, Y. Bouhnik8, L. Peyrin-biroulet9, C. Gilletta10, X. Roblin11, G. Pineton de chambrun7, L. Vuitton12, A. Bourrier13, S. Nancey14, J.M. Gornet15, S. Nahon16, G. Bouguen17, S. Viennot18, P. Benjamin19, M. Fumery20, GETAID

Created: Thursday, 30 January 2020, 10:12 AM
P719: Determinants of tobacco consumption in the Swiss IBD cohort
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Grueber M.*1, Clair Willi C.2, Allez M.3, Biedermann L.4, Fournier N.5, Schöpfer A.6, Vavricka S.7, Juillerat P.8, Macpherson A.J.9

Created: Wednesday, 20 February 2019, 10:36 AM
P719: Does radiation to the pelvis portend worse ileal pouch outcomes? An international multi-institution collaborative study
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Lightner1*, A. Spinelli2, N. McKenna1, J. Warusavitarne3, P. Fleshner4

Created: Thursday, 21 February 2019, 9:14 AM
P719: Identification of differentially expressed genes between AIEC and non-AIEC clinical isolates during in vitro cell infection
Year: 2022
Source: ECCO'22
Authors: Bonet Rossinyol, Q.(1);Camprubí-Font, C.(1);Lopez-Siles, M.(1);Martinez-Medina, M.(1);
Created: Friday, 11 February 2022, 3:56 PM
P719: Symptomatic improvement and long-term stability of ulcerative colitis symptoms over 3 years of ozanimod treatment
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Danese, S.(1)*;Abreu, M.T.(2);Afzali, A.(3);Canavan, J.B.(4);Jain, A.(4);Wu, H.(4);Petersen, A.(4);Panaccione, R.(5);Wolf, D.C.(6);
Created: Friday, 14 July 2023, 11:12 AM
P719: Update of a network meta-analysis of efficacy and safety of different intravenous iron compounds in patients with IBD and anaemia
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Aksan*1,2, H. Işık2, H. H. Radeke1,3, A. Dignass4, J. Stein1,5

Created: Friday, 22 February 2019, 9:41 AM
P720 Recurrent rectovaginal fistula in patients with Crohn’s disease: How can we improve the success rate of graciloplasty? A bi-centric European study in 30 patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Frontali1, M. Rottoli2, A. Chierici1, G. Poggioli2, Y. Panis3

Created: Thursday, 30 January 2020, 10:12 AM
P720: Drug survival of first-line biologics in inflammatory bowel disease: large single-centre experience from UR-CARE
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Hanzel, J.(1)*;Supovec, E.(2);Smrekar, N.(1);Koželj, M.(1);Kurent, T.(1);Štabuc, B.(1);Novak, G.(1);Drobne, D.(1);
Created: Friday, 14 July 2023, 11:12 AM
P720: Efficacy of exclusive enteral nutrition for induction and partial enteral nutrition for maintenance of remission in newly diagnosed paediatric and adolescent Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Ikeda*1, T. Ogashiwa1, Y. Nakamori1, T. Mitsui1, K. Chida1, Y. Hashimoto1, Y. Tamura1, S. Maeda2, H. Kimura1, R. Kunisaki1

Created: Friday, 22 February 2019, 9:41 AM
P720: Is there a difference in trough levels and immunogenicity between Crohn’s disease and ulcerative colitis patients treated with infliximab?
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Perdigoto, C. Macedo*, F. Portela, S. Lopes, M. Ferreira, M. Ferreira, S. Mendes, L. Tomé

Created: Thursday, 21 February 2019, 9:14 AM
P720: Similar risk of infection with SARS-CoV-2 in immunocompromised and immunocompetent patients with inflammatory bowel disease and healthy controls
Year: 2022
Source: ECCO'22
Authors: Kante, B.(1);Vuyyuru, S.K.(1);Gupta, R.(2);Dwivedi, T.(2);Kumar, P.(1);Mundhra, S.(1);Golla, R.(1);Virmani, S.(1);Verma, M.(1);Makharia, G.(1);Ahuja, V.(1);Kedia, S.(1);
Created: Friday, 11 February 2022, 3:56 PM
P720: Use of proton pump inhibitors associated with a markedly increased risk of microscopic colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bonderup O.*1, Lauge Nielsen G.2, Dall M.3, Pottegård A.3, Hallas J.3

Created: Wednesday, 20 February 2019, 10:36 AM